Pathogenic polymorphisms of other inflammatory genes like NRF2, IL1α, IL1β, IL6, IL8, and CXCR2 have also been identified in Tunisian and Egyptian breast cancer patients (126–130). This evidence concerns the gene IL1B and breast carcinoma.